AARTIPHARM
Invest Now

Aarti Pharmalabs Share Price
₹713.20 -20.4 (-2.78%)
21 Apr, 2025 13:41
Start SIP in
AARTIPHARM
Performance
- Low
- ₹708
- High
- ₹737
- 52 Week Low
- ₹471
- 52 Week High
- ₹837
- Open Price₹734
- Previous Close₹734
- Volume236,469
Investment Returns
- Over 1 Month -7.23%
- Over 3 Month + 4.94%
- Over 6 Month + 16.95%
- Over 1 Year + 42.98%
Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!
Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.9
- PEG Ratio
- 0.9
- Market Cap Cr
- 6,463
- P/B Ratio
- 3.5
- Average True Range
- 44.9
- EPS
- 27.51
- Dividend Yield
- 0.5
- MACD Signal
- -8.14
- RSI
- 52.42
- MFI
- 59.95
Aarti Pharmalabs Financials
Aarti Pharmalabs Technicals
EMA & SMA
Current Price
₹713.20
-20.4
(-2.78%)

-
- Bearish Moving Average 6
-
- Bullish Moving Average 10
- 20 Day
- ₹716.28
- 50 Day
- ₹713.82
- 100 Day
- ₹691.61
- 200 Day
- ₹651.26
Resistance and Support
726.55
- R3 770.95
- R2 753.80
- R1 743.70
- S1 716.45
- S2 699.30
- S3 689.20
Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-05 | Quarterly Results, Dividend & Others | To consider other business matters. per share(40%)Interim Dividend |
2024-10-28 | Quarterly Results | |
2024-08-05 | Quarterly Results | |
2024-05-13 | Audited Results & Final Dividend | |
2024-02-07 | Quarterly Results & Interim Dividend |
Aarti Pharmalabs F&O
About Aarti Pharmalabs
- NSE Symbol
- AARTIPHARM
- BSE Symbol
- 543748
- Managing Director
- Mr. Narendra J Salvi
- ISIN
- INE0LRU01027
Similar Stocks to Aarti Pharmalabs
Aarti Pharmalabs FAQs
Aarti Pharmalabs share price is ₹713 As on 21 April, 2025 | 13:27
The Market Cap of Aarti Pharmalabs is ₹6463.4 Cr As on 21 April, 2025 | 13:27
The P/E ratio of Aarti Pharmalabs is 25.9 As on 21 April, 2025 | 13:27
The PB ratio of Aarti Pharmalabs is 3.5 As on 21 April, 2025 | 13:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.